宝济药业-B(02659)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02659 宝济药业-B

未开盘 09-03 16:08:19

16.430

-0.230

-1.38%

最高17.130	最低16.110	成交量64.84万
今开16.660	昨收16.660	日振幅6.12%
总市值53.23亿	流通市值25.14亿	总股本3.24亿
成交额1,074万	换手率0.42%	流通股本1.53亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02659","market":"HK","secType":"STK","nameCN":"宝济药业-B","latestPrice":16.43,"timestamp":1788422899232,"preClose":16.66,"halted":0,"volume":648400,"delay":0,"changeRate":-0.01380552220888358,"floatShares":153000000,"shares":324000000,"eps":-1.36,"marketStatus":"未开盘","change":-0.23,"latestTime":"09-03 16:08:19","open":16.66,"high":17.13,"low":16.11,"amount":10735582,"amplitude":0.061224,"askPrice":16.59,"askSize":2500,"bidPrice":16.43,"bidSize":900,"shortable":0,"etf":0,"ttmEps":-1.3,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788485400000},"marketStatusCode":0,"adr":0,"listingDate":1765296000000,"exchange":"SEHK","adjPreClose":16.66,"openAndCloseTimeList":[[1788399000000,1788408000000],[1788411600000,1788422400000]],"volumeRatio":1.3222328849095455,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02659","defaultTab":"news","newsList":[{"id":"1139013431","title":"宝济药业-B 9月3日回购24.09万股股份，耗资约399.14万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139013431","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139013431?lang=zh_cn&edition=full","pubTime":"2026-09-03 20:06","pubTimestamp":1788437171,"startTime":"0","endTime":"0","summary":"上海宝济药业股份有限公司2026年9月3日公告显示，公司于当日于香港联交所场内回购股票24.09万股，占回购前公司已发行股本的0.15831%。最高回购价每股17.12港元，最低回购价每股16.15港元，总耗资约399.14万港元。此次交易完成后，公司已发行股本为151,929,950股，库藏股为2,397,300股，合计股本总数仍为154,327,250股。截至目前，已根据该授权在包括香港联交所在内的证券交易所合计回购股份2,397,300股，占授权通过当日已发行股本的1.55339%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宝济药业-B 9月3日回购24.09万股股份，耗资约399.14万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664712088","title":"宝济药业-B(02659)9月3日耗资约399.14万港元回购24.09万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664712088","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664712088?lang=zh_cn&edition=full","pubTime":"2026-09-03 20:01","pubTimestamp":1788436894,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宝济药业-B(02659)公布，2026年9月3日耗资约399.14万港元回购24.09万股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1491739.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148373891","title":"宝济药业-B回购119,500股，总额约199.43万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1148373891","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148373891?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:52","pubTimestamp":1788342748,"startTime":"0","endTime":"0","summary":"宝济药业-B于2026年9月2日发布翌日披露报表。公告显示，公司于同日通过香港联交所场内回购H股普通股119,500股，占当日公司已发行股本约0.07847%。回购价格区间每股16.46港元至16.96港元，共计1,994,328港元，折合约199.43万港元。本次回购完成后，公司已发行股份数为152,170,850股，库藏股增至2,156,400股，总股本154,327,250股。公告同时披露，公司于2026年5月26日曾获得股东大会批准，可回购股份总数为15,432,725股。本次公告由执行董事刘彦君签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宝济药业-B回购119,500股，总额约199.43万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154221701","title":"宝济药业-B发布2026年8月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1154221701","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154221701?lang=zh_cn&edition=full","pubTime":"2026-09-02 16:42","pubTimestamp":1788338535,"startTime":"0","endTime":"0","summary":"上海宝济药业股份有限公司于2026年9月2日披露2026年8月股份变动月报表。报告显示，截至2026年8月31日，公司法定/注册股本保持不变，累计为人民币65,196,293元，其中 H 股法定/注册股本为人民币30,865,450元，内资股法定/注册股本为人民币34,330,843元。H 股数量与上月相同，为154,327,250股；内资股数量仍为171,654,215股。报告期内未有新增发行，亦无股份注销。公司根据股东大会决议于2026年8月31日回购H股184,800股，成交均价为每股港币16.1859元，上述回购股份已被列作公司库存股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170841805","title":"宝济药业-B 9月1日回购119,200股，耗资约199.42万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170841805","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1170841805?lang=zh_cn&edition=full","pubTime":"2026-09-01 18:06","pubTimestamp":1788257174,"startTime":"0","endTime":"0","summary":"宝济药业-B于2026年9月1日发布翌日披露报表，宣布在香港联交所场内回购119,200股H股，占回购前公司已发行股份总数的约0.07821%。本次回购的每股价格介乎每股港币16.48元至16.81元，平均购回价约港币16.7296元，合计斥资约199.42万港元。本次回购完成后，公司于9月1日的已发行股份数降至152,290,350股，库藏股数增至2,036,900股，总股份数为154,327,250股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宝济药业-B 9月1日回购119,200股，耗资约199.42万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664588738","title":"宝济药业-B(02659)9月1日斥资199.42万港元回购11.92万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664588738","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664588738?lang=zh_cn&edition=full","pubTime":"2026-09-01 18:05","pubTimestamp":1788257151,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宝济药业-B(02659)发布公告，该公司于2026年9月1日斥资199.42万港元回购11.92万股股份，每股回购价格为16.48-16.81港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109629638","title":"宝济药业-B 8月31日回购18.48万股股份，涉资约299.12万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1109629638","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109629638?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:01","pubTimestamp":1788170485,"startTime":"0","endTime":"0","summary":"宝济药业-B于2026年8月31日发布公告，披露当天在香港联交所回购184,800股H股，约占该公司已发行股本0.12111%。回购价格最高每股16.66港元、最低每股15.69港元，总耗资约299.12万港元。回购完成后，公司已发行股本为152,409,550股，库藏股为1,917,700股。公告显示，该公司于2026年5月26日通过了本次回购授权，授权回购股份总数为15,432,725股；截至公告日，公司已在包括本交易所在内的公开市场合计回购1,917,700股，剩余可回购额度为13,515,025股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宝济药业-B 8月31日回购18.48万股股份，涉资约299.12万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071499","title":"宝济药业-B(02659)8月31日斥资299.12万港元回购18.48万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071499","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663071499?lang=zh_cn&edition=full","pubTime":"2026-08-31 17:58","pubTimestamp":1788170319,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宝济药业-B(02659)发布公告，该公司于2026年8月31日斥资299.12万港元回购18.48万股股份，每股回购价格为15.69-16.66港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489555.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662806127","title":"一图读懂宝济药业(02659)2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2662806127","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662806127?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:25","pubTimestamp":1787912715,"startTime":"0","endTime":"0","summary":"更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136833502","title":"宝济药业-B（02659）发布董事会提名委员会工作细则　完善公司治理架构","url":"https://stock-news.laohu8.com/highlight/detail?id=1136833502","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136833502?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:23","pubTimestamp":1787912594,"startTime":"0","endTime":"0","summary":"2024年6月14日，上海宝济药业股份有限公司披露《董事会提名委员会工作细则》。公司依照《中华人民共和国公司法》《香港联合交易所有限公司证券上市规则》及《企业管治守则》等相关法规和《上海宝济药业股份有限公司章程》，正式设立董事会提名委员会并明确其职责与运作机制，以进一步强化董事会决策功能，完善公司治理结构。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662069243","title":"宝济药业-B(02659)中期业绩：亏损收窄、现金充沛，优质管线矩阵筑牢长期价值","url":"https://stock-news.laohu8.com/highlight/detail?id=2662069243","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662069243?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:09","pubTimestamp":1787911758,"startTime":"0","endTime":"0","summary":"智通财经APP讯，8月28日，宝济药业-B 发布2026年中期业绩。2026年上半年，宝济药业经营质量显著改善，期内亏损显著缩减至1.54亿元，同比大幅收窄16.1%;期末持有现金及现金等价物余额10.42亿元，账面资金充裕。宝济药业在商业化维度实现全面突破：国内最先进的重组人玻璃酸酶葆舒宜于3月获国家药监局批准上市，用于辅助皮下输液。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134854696","title":"宝济药业-B2026年中期营收9.90百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134854696","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134854696?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:08","pubTimestamp":1787911683,"startTime":"0","endTime":"0","summary":"宝济药业-B发布截至2026年6月30日止六个月的中期业绩，报告期内实现营收9.90百万元，较上年同期的41.99百万元下降76.5%。经营活动所用现金净流出为146.62百万元，上年同期则为105.19百万元。从成本结构来看，报告期内公司研发投入为92.57百万元，同比减少16.6%，行政开支为40.62百万元，同比降低12.0%，两项在总支出中占比较大。报告期内，销售材料收入约1.17百万元，同比增长19.0%。报告期内无新的许可收入，去年同期则有一次性许可收入40.00百万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"宝济药业-B2026年中期营收9.90百万元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1117166442","title":"宝济药业-B（02659）拟于8月28日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1117166442","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117166442?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:36","pubTimestamp":1787042196,"startTime":"0","endTime":"0","summary":"上海宝济药业股份有限公司（股票代码：02659，以下简称“宝济药业-B”）8月18日发布公告称，公司董事会将于2026年8月28日（星期五）召开会议，届时将审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩，并处理其他相关事项。\n公告显示，董事会成员包括：执行董事刘彦君博士、王征女士及李翠女士；职工代表董事孙玉华先生；非执行董事林佳陵女士、刁雋桓先生及Li Chen先生；以及独立非执行董事蔡仲曦先生、曾凡一博士、鞠佃文博士及张森泉先生。\n公司董事长兼执行董事刘彦君博士代表董事会签署本次公告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133270559","title":"宝济药业-B 7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1133270559","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133270559?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:49","pubTimestamp":1785746973,"startTime":"0","endTime":"0","summary":"上海宝济药业股份有限公司于2026年8月3日发布了2026年7月的股份变动月报表，报告期截至2026年7月31日。根据公告内容，截至报告期末，公司法定/注册股本总额为人民币65,196,293元，保持不变。2026年7月6日至7月28日期间，公司通过多次回购合计1,637,700股H股，并将回购股份全部列作库存股份。内资股方面未发生库存股份变动，已发行总数继续保持在171,654,215股。截至2026年7月31日，公司已满足适用的香港联交所最低公众持股量要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114901191","title":"宝济药业-B：7月28日回购6.31万股，耗资约118.53万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114901191","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114901191?lang=zh_cn&edition=full","pubTime":"2026-07-28 17:56","pubTimestamp":1785232583,"startTime":"0","endTime":"0","summary":"上海宝济药业股份有限公司于2026年7月28日发布公告，披露其在香港联交所场内回购股票。公司当日回购普通股63,100股，约占公司已发行股本152,657,450股的0.04133%，回购价格介乎每股18.25港元至18.82港元，合计耗资约118.53万港元。本次回购完成后，公司已发行股本降至152,594,350股，库存股份数增至1,732,900股，已发行股份总数仍为154,327,250股。公司表示，本次回购已获董事会正式授权，并遵照相关上市规则和适用法律法规执行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"宝济药业-B：7月28日回购6.31万股，耗资约118.53万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172411896","title":"宝济药业-B：7月27日回购7.06万股股份，总额约128.49万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172411896","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172411896?lang=zh_cn&edition=full","pubTime":"2026-07-27 18:11","pubTimestamp":1785147081,"startTime":"0","endTime":"0","summary":"宝济药业-B于2026年7月27日发布公告，称公司当日于香港联交所回购H股70,600股，占该次回购前已发行股本的约0.04623%，每股回购价介乎17.47港元至18.54港元，合计支付约128.49万港元。公告显示，此次回购完成后，公司已发行股本减少至152,657,450股，库藏股数量增至1,669,800股，总股本仍为154,327,250股。根据此前于2026年5月26日通过的购回授权，宝济药业-B最多可回购15,432,725股股份，截至目前已合计回购1,669,800股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宝济药业-B：7月27日回购7.06万股股份，总额约128.49万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654019524","title":"宝济药业-B(02659)7月27日斥资128.49万港元回购7.06万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654019524","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654019524?lang=zh_cn&edition=full","pubTime":"2026-07-27 18:08","pubTimestamp":1785146901,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宝济药业-B(02659)发布公告，于2026年7月27日斥资128.49万港元回购7.06万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654050994","title":"宝济药业-B于7月24日斥资199.42万港元回购11.52万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654050994","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654050994?lang=zh_cn&edition=full","pubTime":"2026-07-26 09:41","pubTimestamp":1785030060,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　宝济药业-B（02659）发布公告，于2026年7月24日，该公司斥资199.42万港元回购11.52万股。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-07-26/doc-inikawyp0573934.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02659","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149756990","title":"宝济药业-B 7月24日回购11.52万股，耗资约199.42万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1149756990","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149756990?lang=zh_cn&edition=full","pubTime":"2026-07-24 17:46","pubTimestamp":1784886391,"startTime":"0","endTime":"0","summary":"2026年7月24日，上海宝济药业股份有限公司发布翌日披露报表，宣布于2026年7月24日在香港联合交易所场内回购H股普通股115,200股，约占前一交易日公司已发行股本的0.07537%。本次回购每股价格介乎17.08港元至17.77港元，合计耗资约199.42万港元。本次交易完成后，公司已发行股份总数降至152,728,050股，库存股份增至1,599,200股，合计154,327,250股。本次回购所涉股份将继续作为库存股份持有。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"宝济药业-B 7月24日回购11.52万股，耗资约199.42万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653083589","title":"宝济药业-B(02659.HK)7月24日斥资199.42万港元回购11.52万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653083589","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653083589?lang=zh_cn&edition=full","pubTime":"2026-07-24 17:44","pubTimestamp":1784886296,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02659"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.baopharma.com","stockEarnings":[{"period":"1week","weight":0.0262},{"period":"1month","weight":-0.0665},{"period":"3month","weight":-0.2394},{"period":"6month","weight":-0.838},{"period":"1year","weight":-0.3772},{"period":"ytd","weight":-0.7881}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":-0.0247},{"period":"3month","weight":0.0101},{"period":"6month","weight":-0.0211},{"period":"1year","weight":-0.0051},{"period":"ytd","weight":-0.0163}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海宝济药业股份有限公司是一家主要从事药品研发业务的中国公司。该公司利用合成生物技术开发及提供重组生物药物，专注于攻克治疗选择有限且药物制造工艺复杂的目标病症。该公司聚焦四大领域，包括大容量皮下给药，抗体介导的自身免疫性疾病，辅助生殖药物及以重组生物制药取代传统生化制品的变革性产品。该公司的核心产品包括SJ02（晟诺娃），是一种长效重组人卵泡刺激素羧基末端肽融合蛋白（FSH-CTP），KJ017是一种重组人透明质酸酶，以及KJ103，是一种创新重组免疫球蛋白G(IgG)降解酶。","exchange":"SEHK","name":"宝济药业-B","nameEN":"BAO PHARMA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"宝济药业-B(02659)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供宝济药业-B(02659)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"宝济药业-B,02659,宝济药业-B股票,宝济药业-B股票老虎,宝济药业-B股票老虎国际,宝济药业-B行情,宝济药业-B股票行情,宝济药业-B股价,宝济药业-B股市,宝济药业-B股票价格,宝济药业-B股票交易,宝济药业-B股票购买,宝济药业-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"宝济药业-B(02659)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供宝济药业-B(02659)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}